Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$674K Sell
3,675
-171
-4% -$31.5K 0.09% 148
2025
Q4
$677K Sell
3,846
-150
-4% -$24.5K 0.09% 138
2025
Q3
$560K Buy
3,996
+24
+0.6% +$3.24K 0.08% 163
2025
Q2
$499K Buy
3,972
+198
+5% +$24.7K 0.08% 169
2025
Q1
$516K Buy
3,774
+22
+0.6% +$3.15K 0.09% 152
2024
Q4
$574K Buy
3,752
+216
+6% +$36.4K 0.1% 142
2024
Q3
$685K Buy
3,536
+289
+9% +$60.5K 0.12% 121
2024
Q2
$753K Buy
3,247
+506
+18% +$110K 0.15% 99
2024
Q1
$591K Buy
2,741
+336
+14% +$78.7K 0.13% 117
2023
Q4
$622K Buy
2,405
+146
+6% +$35.9K 0.17% 94
2023
Q3
$581K Buy
2,259
+195
+9% +$52.2K 0.19% 85
2023
Q2
$588K Buy
2,064
+215
+12% +$64K 0.21% 83
2023
Q1
$514K Buy
1,849
+34
+2% +$9.41K 0.22% 78
2022
Q4
$503K Buy
1,815
+149
+9% +$42.1K 0.26% 74
2022
Q3
$445K Buy
1,666
+109
+7% +$23.1K 0.27% 69
2022
Q2
$318K Sell
1,557
-165
-10% -$33.7K 0.2% 92
2022
Q1
$363K Sell
1,722
-28
-2% -$6.09K 0.21% 101
2021
Q4
$420K Buy
+1,750
New +$450K 0.23% 90

Other funds holding BIIB

Wahed Invest's BIIB Position: Q1 2026 in Review

Wahed Invest reduced its Biogen (BIIB) stake by 4.4% in Q1 2026, selling an estimated $31.5K and leaving 3,675 shares worth $674K. The position accounts for 0.09% of the portfolio, ranked #148.

Wahed Invest first reported a position in BIIB in Q4 2021 and has held it in 18 quarters since. The position peaked at $753K in Q2 2024. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Wahed Invest held 3,675 shares of Biogen worth $674K as of Q1 2026.
  • Wahed Invest sold 171 Biogen shares in Q1 2026, an estimated $31.5K.
  • Biogen made up 0.09% of Wahed Invest's portfolio in Q1 2026, its #148 holding.
  • Wahed Invest first reported a position in Biogen in Q4 2021 and has held it in 18 quarters since.
  • Wahed Invest's Biogen position peaked at $753K in Q2 2024.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Wahed Invest's 13F filing for Q1 2026, filed 13 May 2026.